论文部分内容阅读
目的:对妊娠期哮喘患者实施普米克令舒雾化吸入治疗的临床观察。方法:回顾性分析我院在2013年4月-2015年4月实施治疗的80例妊娠期哮喘患者,将其分成两组,其中对照组患者实施常规抗炎+茶碱等药物治疗,观察组患者加上普米克令舒雾化吸入治疗,对比分析两组患者的临床疗效和临床症状改善情况。结果:和对照组相比,观察组患者的临床治疗总有效率显著偏高,患者的喘息平均消失时间和哮呜音平均消失时间显著偏短,差异显著(P<0.05)。结论:在妊娠期哮喘患者临床治疗中普米克令舒雾化吸入治疗的应用,能够取得良好临床效果吗,值得推广。
Objective: To observe the effect of pulmicort respiration inhalation therapy on asthma in pregnancy. Methods: A retrospective analysis of 80 cases of gestational asthma patients who were treated in our hospital from April 2013 to April 2015 were divided into two groups. The patients in the control group were treated with conventional anti-inflammatory drugs and theophylline, and the observation group Patients with pulmicort respirator inhalation therapy, comparative analysis of two groups of patients with clinical efficacy and improvement of clinical symptoms. Results: Compared with the control group, the total effective rate of clinical treatment in the observation group was significantly higher than that in the control group. The mean disappearance time of wheezing and the mean disappearance time of asthma arousal were significantly shorter (P <0.05). Conclusion: The application of pulmicort respiration inhalation in the clinical treatment of patients with asthma during pregnancy can achieve good clinical results, which is worthy of promotion.